How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,019 results for

"covid 19" OR "novel coronavirus"

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. Full Text available with Trip Pro

Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. To investigate the clinical and imaging characteristics of computed tomography (CT) in novel coronavirus pneumonia (NCP) caused by SARS-CoV-2.A retrospective analysis was performed on the imaging findings of patients confirmed with COVID-19 pneumonia who had chest CT scanning and treatment after disease onset. The clinical and imaging data were analyzed.Fifty patients were enrolled, including

2020 Journal of Infection

82. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia. Full Text available with Trip Pro

The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia. The study was aimed at investigating the characteristics of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus (2019-nCoV) pneumonia.Children with 2019-nCoV pneumonia or with respiratory syncytial virus (RSV) pneumonia were included. Data including lymphocyte subsets and serum cytokines were collected and analyzed.56 patients were

2020 Journal of Infection

83. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Full Text available with Trip Pro

Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Since December 2019, 2019 novel coronavirus pneumonia emerged in Wuhan city and rapidly spread throughout China and even the world. We sought to analyse the clinical characteristics and laboratory findings of some cases with 2019 novel coronavirus pneumonia .In this retrospective study, we extracted the data on 95 patients with laboratory (...) -confirmed 2019 novel coronavirus pneumonia in Wuhan Xinzhou District People's Hospital from January 16th to February 25th, 2020. Cases were confirmed by real-time RT-PCR and abnormal radiologic findings. Outcomes were followed up until March 2th, 2020.Higher temperature, blood leukocyte count, neutrophil count, neutrophil percentage, C-reactive protein level, D-dimer level, alanine aminotransferase activity, aspartate aminotransferase activity, α - hydroxybutyrate dehydrogenase activity, lactate

2020 Respiratory research

84. Pediatric otolaryngology workflow changes in a community hospital setting to decrease exposure to novel coronavirus. Full Text available with Trip Pro

Pediatric otolaryngology workflow changes in a community hospital setting to decrease exposure to novel coronavirus. To develop a workflow algorithm for physicians and staff to decrease cross contamination and minimize exposure to Coronavirus Disease -19 (COVID-19) in pediatric otolaryngology at a community pediatric hospital.PubMed and Google Scholar searches were carried out using the keywords. Pertinent clinical information related to pediatric otolaryngology was reviewed from journals (...) -19. Algorithms and guidelines were reviewed and revisions made at each phase of the pandemic related to in-clinic visits, telemedicine visits, and surgical cases.In the era of the COVID-19 pandemic, otolaryngologists and pediatric otolaryngologists are amongst sub-specialties with an increased risk of exposure. It is imperative that a modification in clinical workflow is created to minimize the risk of exposure to providers and staff while continuing to provide care to patients.The COVID-19

2020 International Journal of Pediatric Otorhinolaryngology

85. COVID-19: Managing the COVID-19 pandemic in care homes

COVID-19: Managing the COVID-19 pandemic in care homes COVID-19: Managing the COVID-19 pandemic in care homes | British Geriatrics Society Toggle main menu visibility Search Search Search COVID-19: Managing the COVID-19 pandemic in care homes tool to recognise deterioration in residents, measure vital signs and communicate concerns to healthcare professionals. Care homes should have standard operating procedures for isolating residents who ‘walk with purpose’ (often referred to as ‘wandering (...) ’) as a consequence of cognitive impairment. Behavioural interventions may be employed but physical restraint should not be used. Care homes should work with General Practitioners, community healthcare staff and community geriatricians to review Advance Care Plans as a matter of urgency with care home residents. This should include discussions about how COVID-19 may cause residents to become critically unwell, and a clear decision about whether hospital admission would be considered in this circumstance. Care

2020 British Geriatrics Society

86. Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the HRS COVID-19 Task Force, ACC Electrophysiology Section, and the AHA Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology

Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the HRS COVID-19 Task Force, ACC Electrophysiology Section, and the AHA Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the HRS COVID-19 Task Force, ACC Electrophysiology Section, and the AHA Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology | Heart Rhythm Society Utility Menu Main (...) navigation Search Leave this field blank Main Menu Breadcrumb , identifies the potential risks of exposure to patients, allied health care staff, industry representatives, and hospital administrators and describes the impact of COVID-19 on cardiac arrhythmias and methods of triage based on acuity and patient comorbidities. Clinical EP Atrial Arrhythmias Heart Failure / CRT Ventricular Arrhythmias Downloads The joint document provides guidance for managing invasive and noninvasive electrophysiology

2020 Heart Rhythm Society

87. AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19

The novel coronavirus, SARS-CoV-2, was first described in December 2019 in patients in Wuhan, China who developed severe pneumonia, and was named coronavirus-19 disease (COVID-19) by the World Health Organization on February 11, 2020. 2 COVID- 19 is estimated to have resulted in 2,896,633 cases in 185 countries with 202,832 deaths as of April 25, 2020. 3 COVID-19 was first reported in the United States (U.S.) on January 20, 2020 and accounted for a total number of 938,154 cases and 53,755 deaths (...) AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19 1 AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta- Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19 Authors: Shahnaz Sultan* 1 , Osama Altayar* 2 , Shazia M. Siddique 3 , Perica Davitkov 4 , Joseph D. Feuerstein 5

2020 American Gastroenterological Association Institute

88. AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19 Full Text available with Trip Pro

pneumonia, and was named coronavirus disease 2019 (COVID-19) by the World Health Organization on February 11, 2020. Huang C. Wang Y. Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 : 497-506 COVID-19 is estimated to have resulted in 2,896,633 cases in 185 countries with 202,832 deaths as of April 25, 2020. Dong E. Du H. Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20 : 533-534 (...) . et al. [Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region]. Zhonghua Gan Zang Bing Za Zhi. 2020; 28 : E003 , Yang P. Ding Y. Xu Z. et al. Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China. medRxiv. 2020; ( 2020.02.28.20028068 ) , Yan S. Song X. Lin F. et al. Clinical characteristics of coronavirus disease 2019 in Hainan, China. medRxiv. 2020

2020 American Gastroenterological Association Institute

89. What is the effect of the COVID-19 pandemic on alcohol use, poisonings, and alcohol-related deaths? What strategies have been used to mitigate alcohol abuse during the COVID-19 pandemic?

What is the effect of the COVID-19 pandemic on alcohol use, poisonings, and alcohol-related deaths? What strategies have been used to mitigate alcohol abuse during the COVID-19 pandemic? Version 1: June 23, 2020 Rapid Review: What is the effect of the COVID-19 pandemic on alcohol use and alcohol-related harms? Prepared by: The National Collaborating Centre for Methods and Tools Date: June 23, 2020 Suggested Citation: National Collaborating Centre for Methods and Tools. (2020). What (...) is the effect of the COVID- 19 pandemic on alcohol use and alcohol-related harms? https://www.nccmt.ca/knowledge- repositories/covid-19-rapid-evidence-service. © 2020. National Collaborating Centre for Methods and Tools, McMaster University. All rights reserved. The National Collaborating Centre for Methods and Tools (NCCMT) is hosted by McMaster University and funded by the Public Health Agency of Canada. The views expressed herein do not necessarily represent the views of the Public Health Agency

2020 COVID-19 Rapid Evidence Service

91. Novel coronavirus-like particles targeting cells lining the respiratory tract. Full Text available with Trip Pro

Novel coronavirus-like particles targeting cells lining the respiratory tract. Virus like particles (VLPs) produced by the expression of viral structural proteins can serve as versatile nanovectors or potential vaccine candidates. In this study we describe for the first time the generation of HCoV-NL63 VLPs using baculovirus system. Major structural proteins of HCoV-NL63 have been expressed in tagged or native form, and their assembly to form VLPs was evaluated. Additionally, a novel procedure

2018 PLoS ONE

92. COVID-19 rapid guideline: delivery of systemic anticancer treatments

COVID-19 rapid guideline: delivery of systemic anticancer treatments COVID-19 rapid guideline: delivery of systemic anticancer treatments NICE guideline Published: 20 March 2020 www.nice.org.uk/guidance/ng161 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence (...) be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 13Contents Contents Overview 4 1 Communicating with patients 5 2 Patients not known to have COVID-19

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

93. COVID-19 rapid guideline: critical care

COVID-19 rapid guideline: critical care COVID-19 rapid guideline: critical care NICE guideline Published: 20 March 2020 www.nice.org.uk/guidance/ng159 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals (...) and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: critical care (NG159) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 11Contents Contents Overview 4 1 Admission to hospital 5 2 Admission to critical care 6 3 Starting, reviewing

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

94. COVID-19 rapid guideline: dialysis service delivery

COVID-19 rapid guideline: dialysis service delivery COVID-19 rapid guideline: dialysis service delivery NICE guideline Published: 20 March 2020 www.nice.org.uk/guidance/ng160 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising (...) . Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: dialysis service delivery (NG160) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 17Contents Contents Overview 4 1 Communicating with patients 5 2 Patients not known

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

95. COVID-19 rapid guideline: delivery of radiotherapy

COVID-19 rapid guideline: delivery of radiotherapy COVID-19 rapid guideline: delivery of radiotherapy NICE guideline Published: 28 March 2020 www.nice.org.uk/guidance/ng162 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising (...) . Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: delivery of radiotherapy (NG162) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 15Contents Contents Overview 4 1 Communicating with patients 6 2 Patients not known

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

96. COVID-19 rapid guideline: severe asthma

COVID-19 rapid guideline: severe asthma COVID-19 rapid guideline: severe asthma NICE guideline Published: 3 April 2020 www.nice.org.uk/guidance/ng166 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals (...) and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: severe asthma (NG166) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 11Contents Contents Overview 4 1 Communicating with patients and minimising risk 5 2 Investigations 7 3 Treatment 8

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

97. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community

COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community NICE guideline Published: 3 April 2020 www.nice.org.uk/guidance/ng165 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE (...) in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community (NG165) © NICE 2020. All rights reserved. Subject to Notice of rights (https

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

98. COVID-19 rapid guideline: haematopoietic stem cell transplantation

COVID-19 rapid guideline: haematopoietic stem cell transplantation COVID-19 rapid guideline: haematopoietic stem cell transplantation NICE guideline Published: 1 April 2020 www.nice.org.uk/guidance/ng164 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence (...) be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: haematopoietic stem cell transplantation (NG164) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 18Contents Contents

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

99. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community

(see table 2 for treatments for managing fever). 5.4 Advise patients to take paracetamol if they have fever and other symptoms that antipyretics would help treat. T ell them to continue only while the symptoms of fever and the other symptoms are present. Until there is more evidence, paracetamol is preferred to non-steroidal anti-inflammatory drugs (NSAIDs) for patients with COVID-19 (see Central Alerting System: novel coronavirus - anti- inflammatory medications). T able T able 2 Antipyretics (...) COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community NICE guideline Published: 3 April 2020 www.nice.org.uk/guidance/ng163 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

100. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response

COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response NICE guideline Published: 9 April 2020 www.nice.org.uk/guidance/ng169 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view (...) in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response (NG169) © NICE 2020. All rights reserved. Subject to Notice of rights (https

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>